Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: N Engl J Med. 2019 Mar 28;380(13):1226–1234. doi: 10.1056/NEJMoa1811714

Figure 4. Subgroup Analysis of Overall Survival.

Figure 4.

Shown are the results of subgroup analyses of the treatment effect on overall survival. Hazard ratios for death in the group that received combination therapy with fulvestrant plus anastrozole, as compared with the group that received anastrozole alone, are shown along with 95% confidence intervals.